iNova Pharmaceuticals (Australia) Pty Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
iNova Pharmaceuticals (Australia) Pty Limited - overview
Established
2006
Location
Sydney, NSW, Australia
Primary Industry
Pharmaceuticals
About
Founded in 2006, and based in Sydney, Australia, iNova Pharmaceuticals (Australia) Pty Limited is a pharmaceutical company that develops, markets, and sells non-prescription medicines and prescription medicines. Its products sell to over 20 countries including Asia, Australasia, and Africa. In 2011, its medicine production was outsourced to a global network of external contract manufacturers. In the same year, it was acquired by Valeant Pharmaceuticals, and the buyout relationship ended in October 2017 when it was acquired by its current owner, Pacific Equity Partners, and Carlyle.
Sine 2017, it acquired multiple medicine brands, such as Creche Guard, Flugon, Contrave, Dequadin, Valda, BLIS Probiotics, and Demazin. iNova Pharmaceuticals (Australia) Pty Limited engages in developing, marketing, and selling drugs for cough cold, flu, anti-fungal, first aid, skincare, suncare, allergy, and pain management. The drug brands, Difflam and Andolex, can relieve pain and discomfort associated with a sore throat and tonsilitis. Duro-truss and Pholtex drug brands can relieve dry and chesty coughs.
DUROMINE PHENTERMINE is used for obese patients to reduce body weight. And the Demazin drug brand used for treating flu symptoms.
Current Investors
Graceway Pharmaceuticals, Inc., TPG, Pacific Equity Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
http://www.inovapharma.com
Verticals
Manufacturing
Company Stage
Merged
Total Amount Raised
Subscriber access only
iNova Pharmaceuticals (Australia) Pty Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | iNova Pharmaceuticals (Australia) Pty Limited | - | ||||||||
| Add-on, Corporate Carve Out | Completed | Mundipharma International Corp.'s consumer health product portfolio | - | ||||||||
| Secondary Buyout | Completed | iNova Pharmaceuticals (Australia) Pty Limited | - | ||||||||
| Buyout | Completed | iNova Pharmaceuticals (Australia) Pty Limited | - | ||||||||
| Buyout | Completed | iNova Pharmaceuticals (Australia) Pty Limited | - |
Displaying 1 - 5 of 8
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.